428 Orally administered endothelin-1 antagonist bosentan for pulmonary hypertension secondary to congenital heart disease (Eisenmenger syndrome)

  • European Journal of Echocardiography, December 2005, European Society of Cardiology
  • DOI: 10.1016/s1525-2167(05)80179-9

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1016/s1525-2167(05)80179-9

In partnership with:

Link to European Society of Cardiology showcase